Familial Partial Lipodystrophy Phenotype Resulting from a Single-Base Mutation in Deoxyribonucleic Acid-Binding Domain of Peroxisome Proliferator-Activated Receptor-γ
Author(s) -
Houshang Monajemi,
Lin Zhang,
Gang Li,
Ellen H. Jeninga,
Henian Cao,
Mario Maas,
Catherine B. Brouwer,
Eric Kalkhoven,
Erik S.G. Stroes,
Robert A. Hegele,
Todd Leff
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2006-1807
Subject(s) - peroxisome proliferator activated receptor gamma , lmna , biology , genetics , mutation , lipodystrophy , peroxisome proliferator activated receptor , phenotype , endocrinology , receptor , gene , virus , antiretroviral therapy , viral load
Familial partial lipodystrophy (FPLD) results from coding sequence mutations either in LMNA, encoding nuclear lamin A/C, or in PPARG, encoding peroxisome proliferator-activated receptor-gamma (PPARgamma). The LMNA form is called FPLD2 (MIM 151660) and the PPARG form is called FPLD3 (MIM 604367).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom